These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Therapeutic approaches to reflux disease: newer approaches and strategies to columnar-lined esophagus. Spechler SJ J Gastroenterol; 2003 Mar; 38 Suppl 15():20-4. PubMed ID: 12698866 [No Abstract] [Full Text] [Related]
4. Unresolved issues in Barrett's esophagus in the new millennium. Falk G Dig Dis; 2000; 18(1):27-42. PubMed ID: 10729735 [No Abstract] [Full Text] [Related]
7. The Second European Endoscopy Forum (Sintra, Portugal, 17-18 June 1999): twenty questions on the esophagogastric junction. Axon A; Lambert R; Robaszkiewicz M; Rösch T; Sonnenberg A Endoscopy; 2000 May; 32(5):411-8. PubMed ID: 10817183 [No Abstract] [Full Text] [Related]
15. Proceedings from an international conference on ablation therapy for Barrett's mucosa. Brittany, France, 31 August-2 September 1997. Bremner CG; Demeester TR Dis Esophagus; 1998 Jan; 11(1):1-27. PubMed ID: 9595228 [TBL] [Abstract][Full Text] [Related]
16. Oesophageal adenocarcinoma. van Lanschot JJ Best Pract Res Clin Gastroenterol; 2006; 20(5):801-2. PubMed ID: 16997161 [No Abstract] [Full Text] [Related]
17. Barrett's esophagus: is dysplasia a reliable marker in surveillance after endoscopic treatment? Ortner MA Curr Gastroenterol Rep; 2001 Oct; 3(5):371-4. PubMed ID: 11560793 [No Abstract] [Full Text] [Related]